Universitätsklinikum Essen

Feasibility and Satisfaction of Young Cancer Survivors Participating in Preventive Interventions. A Subgroup Analysis of the Care for CAYA Program (CFC-P) (2020) Elmers S, Beitzen-Heineke A, Von Grundherr J, Jensen W, Koch B, Mann J, Salchow J, et al. Conference contribution Health Problems and Quality of Life of Young Cancer Survivors in the Comprehensive Care for CAYA Program (2020) Elmers S, Beitzen-Heineke A, Von Grundherr J, Jensen W, Koch B, Mann J, Salchow J, et al. Conference contribution Serio - Side Effect Registry in Immuno-Oncology (2020) Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel ME, et al. Conference contribution Medizinische Betreuung von jungen Frauen mit Ullrich-Turner-Syndrom in Deutschland (2020) Dörr HG, Bettendorf M, Binder G, Braemswig J, Hauffa BP, Holterhus PM, Mohnike K, et al. Journal article EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees (2020) Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, et al. Journal article Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study (2020) Lieb M, Tagay S, Breidenstein A, Hepp T, Le Guin CH, Scheel JF, Lohmann DR, et al. Journal article aEEG Use in Pediatric Critical Care—An Online Survey (2020) Bruns N, Felderhoff-Müser U, Dohna-Schwake C, Wölfle J, Müller H Journal article Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas -A German Survey (2020) Elbelt U, Schlaffer SM, Buchfelder M, Knappe UJ, Vila G, Micko A, Deutschbein T, et al. Journal article, Review article Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review (2020) Salchow J, Mann J, Koch B, von Grundherr J, Jensen W, Elmers S, Straub LA, et al. Journal article Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. (2020) Zimmer L, Livingstone E, Hassel JC, Fluck M, Eigentler T, Loquai C, Haferkamp S, et al. Journal article